Cargando…
Systemically administered anti-TNF therapy ameliorates functional outcomes after focal cerebral ischemia
BACKGROUND: The innate immune system contributes to the outcome after stroke, where neuroinflammation and post-stroke systemic immune depression are central features. Tumor necrosis factor (TNF), which exists in both a transmembrane (tm) and soluble (sol) form, is known to sustain complex inflammato...
Autores principales: | Clausen, Bettina Hjelm, Degn, Matilda, Martin, Nellie Anne, Couch, Yvonne, Karimi, Leena, Ormhøj, Maria, Mortensen, Maria-Louise Bergholdt, Gredal, Hanne Birgit, Gardiner, Chris, Sargent, Ian I L, Szymkowski, David E, Petit, Géraldine H, Deierborg, Tomas, Finsen, Bente, Anthony, Daniel Clive, Lambertsen, Kate Lykke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4272527/ https://www.ncbi.nlm.nih.gov/pubmed/25498129 http://dx.doi.org/10.1186/s12974-014-0203-6 |
Ejemplares similares
-
Post-stroke inflammation—target or tool for therapy?
por: Lambertsen, Kate Lykke, et al.
Publicado: (2018) -
Bone Marrow-Derived IL-1Ra Increases TNF Levels Poststroke
por: von Linstow, Christian Ulrich, et al.
Publicado: (2021) -
Spontaneous ischaemic stroke lesions in a dog brain: neuropathological characterisation and comparison to human ischaemic stroke
por: Thomsen, Barbara Blicher, et al.
Publicado: (2017) -
Cell therapy centered on IL-1Ra is neuroprotective in experimental stroke
por: Clausen, Bettina Hjelm, et al.
Publicado: (2016) -
Conditional ablation of myeloid TNF increases lesion volume after experimental stroke in mice, possibly via altered ERK1/2 signaling
por: Clausen, Bettina Hjelm, et al.
Publicado: (2016)